Oligonucleotides are short strands of synthetic single-stranded DNA or RNA. They are commonly used as probes in scientific research, as primers in DNA sequencing and amplification, and as antisense oligonucleotides (ASOs) to modulate gene expression. Oligonucleotides find major application in fields such as biotechnology research, PCR, DNA sequencing, gene synthesis, antisense therapy and in molecular diagnostics. Gene synthesis in particular is an emerging field which uses oligos for applications spanning from gene editing to vaccine and therapeutic development.

The global oligonucleotide synthesis market is estimated to be valued at US$ 3,962.67 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity

The rising drug development activities across pharmaceutical and biotechnology industries present lucrative growth opportunities for oligonucleotide synthesis market. Manufacturers are increasingly focusing on oligonucleotides for applications in gene therapy, RNA interference (RNAi) and antisense technologies that are commonly used approaches in modern drug discovery. Particularly, gene therapy utilizes oligonucleotides as tools for conditions with high unmet needs involving rare or complex genetic disorders. Additionally, continuous technological advancements in oligonucleotide synthesis technologies to enhance the yields and reduce costs of long oligonucleotides will further aid the market growth over the forecast period.

Porter's Analysis
Threat of new entrants: Low economies of scale required and high capital requirements for production and R&D acts as a barrier for new entrants.

Bargaining power of buyers: Buyers have low bargaining power due to differentiated products and intellectual property owned by existing players.

Bargaining power of suppliers: Suppliers have moderate bargaining power with existence of alternative raw material sources.

Threat of new substitutes: Threat from new substitutes is moderate as oligonucleotides have applications across diverse sectors.

Competitive rivalry: Intense competition exists among existing players due to presence of large number of global and regional players.

SWOT Analysis
Strengths: Increasing demand from biotechnology and pharmaceutical industries, technological advancements lowering production cost.
Weaknesses: High capital investment and processing requirements, limited design flexibility.
Opportunities: Potential new applications in gene therapy, precision medicine and biofuel sector. Untapped emerging markets in Asia Pacific.
Threats: Stringent regulatory approvals and intellectual property issues, substitution threat from emerging techniques like CRISPR.

Key Takeaways
The Global Oligonucleotide Synthesis Market Size is expected to witness high growth during the forecast period of 2023 to 2030. The global oligonucleotide synthesis market is estimated to be valued at US$ 3962.67 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.

North America currently dominates the market followed by Europe. However, Asia Pacific is expected to witness the fastest growth owing to increasing investments in biotechnology and pharmaceutical research in countries like China and India.

Key players operating in the Oligonucleotide Synthesis market are Thermo Fisher Scientific, Sigma-Aldrich Corporation, GE Healthcare, Integrated DNA Technologies, Inc., TriLink Biotechnologies€TM, Inc, BioAutomation Corporation, Twist Bioscience, Shanghai SynTheAll Pharmaceutical Co., CUSABIO Technology LLC, Synbio Technologies, GENEWIZ, Eurofins Scientific, Agilent Technologies, Kaneka Eurogentec S.A., and LGC, Biosearch Technologies. Thermo Fisher Scientific holds the leading market share due to its wide product portfolio and global presence. Sigma-Aldrich Corporation focuses on niche customized oligonucleotides. Other regional players are expanding through collaborations and acquisitions to strengthen their market position.

Get more insights on this topic:

https://www.dailyprbulletin.com/oligonucleotide-synthesis-market-size-market-share-analysis/